(Received for publication, June 25, 1996, and in revised form, September 2, 1996)
From the Institut de Pharmacologie et de Biologie Structurale, CNRS, UPR 9062, 205 route de Narbonne, 31077 Toulouse Cedex, France
Regulation of neutrophil responses is known to involve tyrosine phosphorylation. Hck, a major neutrophil protein-tyrosine kinase, becomes expressed during differentiation of human promyelocytic NB4 cells into neutrophil-like cells. Hck is mainly localized in a secretory granule-enriched cell fraction, but it is also present in a granule-free membrane fraction and the cytosol. Hck is rapidly and transiently activated upon stimulation of differentiated NB4 cells or human neutrophils with serum-opsonized zymosan or the calcium ionophore A23187, but not by phorbol 12-myristate 13-acetate. In NB4 cells, Hck is also weakly activated by fMet-Leu-Phe. Cell fractionation showed that opsonized zymosan and A23187 induce Hck activation in distinct subcellular fractions. Both stimuli activate Hck in the secretory granule-enriched fraction, but only A23187 activates the kinase in the granule-free membrane fraction. Our results suggest that Hck might regulate early signal transduction events induced by opsonized zymosan and A23187, and that the different subcellular fractions of Hck might serve discrete functions, one of which could be regulation of the degranulation response.
Tyrosine phosphorylation is involved in the regulation of all major neutrophil responses: respiratory burst, degranulation, and phagocytosis (Ref. 1, and references therein). The extracellular ligands that initiate this tyrosine phosphorylation all appear to bind to receptors without intrinsic protein-tyrosine kinase (PTK)1 activity, so that the responsible PTKs must be of the non-receptor type (1).
Hck (hematopoietic cell kinase) is a non-receptor PTK of the Src family
which is almost exclusively found in myeloid cells, predominantly in
neutrophils (2, 3). Two isoforms of Hck exist, proteins of 59 and 61 kDa in humans, that are generated by alternative translation (4, 5).
p59hck is exclusively membrane-bound, whereas p61hck
can be membrane-bound or cytosolic (4, 5, 6). Hck is involved in the
regulation of FcRIIIB-mediated neutrophil activation (7) and
Fc
RI- and Fc
RII-linked monocyte activation (8, 9, 10), in the
production of tumor necrosis factor by macrophages (11), and in the
signaling of lipopolysaccharide and urokinase receptors in monocytes
(12, 13). Under certain conditions, phagocytosis is reduced in
macrophages of Hck-deficient mice (14). Furthermore, Hck was shown to
have overlapping roles with other Src family PTKs, i.e. with
Src in osteoclast functioning (15) and with Fgr in
integrin-dependent neutrophil activation (16). These
results indicate that Hck is involved in many signal transduction pathways of myeloid cells, and that it can serve several functions even
within a cell type.
It is conceivable that an enzyme such as Hck could serve more than one
function within a cell due to its sequestration into several cellular
compartments. We have shown that Hck is mainly localized on the
membrane of azurophil granules in human neutrophils, but that it is
also present in a granule-free membrane fraction and in the cytosol
(6). During phagocytosis, Hck translocates with the azurophil granules
to the phagosomal membrane (6) which is the major site for granule
fusion in the course of this process (17). Furthermore, 20% of
p59hck are localized on caveolae in monocytes (5), and finally,
a partial association of Hck with the plasma membrane is suggested by
its implication in FcR signaling (7, 8, 9, 10). Therefore, Hck is a
multicompartmental enzyme, but at present it is not known whether the
different subcellular fractions of the kinase are involved in different
signal transduction pathways. In this study, we identified stimuli that
activate Hck in granulocytes. We tested whether these stimuli can
activate selectively Hck in different subcellular fractions, and we
searched for a link between the subcellular localization of the
activated Hck forms and the function of the respective cellular
response.
All-trans-retinoic acid
was dissolved and stored at 10 mM in ethanol at 80 °C.
Zymosan A yeast particles were opsonized (covered with complement
factors and immunoglobulins) with human serum as described (18). PMA
was prepared at 1 mg/ml in dimethyl sulfoxide and stored at
80 °C.
Formyl-methionyl-leucylphenylalanine (fMLP) was solubilized in
methanol at 1 M, then diluted with H2O to 1 mM, and kept at
20 °C. The calcium ionophore A23187
was stored at 10 mM in dimethyl sulfoxide at
20 °C.
All these reagents were from Sigma. Sodium vanadate
(from Amersham) was prepared as reported (19) and stored in the dark at
4 °C for maximally 2 months. Polyclonal rabbit anti-Hck antiserum or
affinity-purified anti-Hck IgG (from Santa Cruz Biotechnology) were
used as described (6).
Human promyelocytic NB4 cells were cultured as described (1). For differentiation into neutrophil-like cells, they were maintained in the presence of 1 µM all-trans-retinoic acid for 5 days, unless otherwise indicated (20). Nonadherent cells were used for experiments. Human neutrophils from healthy donors were isolated by dextran sedimentation and centrifugation through Ficoll-Hypaque as reported (21), and were resuspended in minimal essential medium buffered with 20 mM Hepes, pH 7.4.
Cell ActivationBefore cell activation, neutrophils were incubated for 5 min at 4 °C with 1 mM diisopropyl fluorophosphate and then washed once. For activation, NB4 cells or neutrophils were taken up at 1 × 107 cells/ml in minimal essential medium buffered with 20 mM Hepes, pH 7.4, prewarmed for 20 min at 37 °C, and then stimulated for various time points with either 4.5 mg/ml serum-opsonized zymosan (OZ), 5 µM fMLP, 100 ng/ml PMA or 5 µM A23187 (final concentrations). Activation was terminated by transferring the tubes to a melting-ice bath and, in Hck experiments, by immediate addition of 5 volumes of ice-cold Hepes-buffered minimal essential medium containing 1 mM EDTA. The cells were then sedimented at 300 × g for 10 min at 4 °C, and either whole cell lysates were prepared or the cells were fractionated as described below. For all experiments, cell activation was monitored in parallel by measurement of the NADPH oxidase and degranulation activities.
Superoxide Production and DegranulationNADPH oxidase
activity was determined as the superoxide dismutase-inhibitable
reduction of cytochrome c by discontinuous measurement as
described (22), using a double-beam Uvikon 930 spectrophotometer (Kontron, France). Superoxide production was calculated from the increase in absorbance at 550 nm with an extinction coefficient of 21.1 mM1 cm
1. Degranulation of
azurophil NB4 cell granules was measured as
-glucuronidase release.
Cells were activated at 5 × 106 cells/ml and then
sedimented. The supernatant containing secreted
-glucuronidase was
frozen until the assay. The cell pellets were resuspended in 8 mM
Na2PO4/KH2PO4, 1%
Triton X-100, 3 mM KCl, 0.5 M NaCl, pH 7.4, passed several times through a 25-gauge needle, and solubilized
overnight at 4 °C. Unsolubilized matter was removed at 11,000 × g for 45 min. The solubilized pellet and cell supernatant were incubated with 1 mg/ml
4-nitrophenyl-
-D-glucopyranosiduronic acid (Merck) as
substrate for
-glucuronidase in 0.1 M acetate buffer at
pH 4.5 for 18 h at room temperature in the dark. Color development
was achieved by addition of 1 volume of 2 N NaOH, and the
samples were measured in a Uvikon 930 spectrophotometer at 405 nm.
NB4 cells were fractionated by differential centrifugation essentially as described previously (6, 23). The cells (2.5 × 107/ml) were cavitated in a nitrogen bomb at 350 p.s.i. for 4 min at 4 °C in the following buffer: 100 mM KCl, 3 mM NaCl, 10 mM Pipes, pH 7.3, 3.5 mM MgCl2, 1000 IU/ml aprotinin, 1 mM EDTA, 5 mM EGTA, 10 µg/ml leupeptin, 2 µg/ml pepstatin, 1 mM diisopropyl fluorophosphate, 30 µM calpeptin, 0.5 mM phenylmethylsulfonyl fluoride, and 1 mM sodium vanadate. In time course experiments the cells were sonicated instead of cavitated with a Branson tip sonifier with 20 strokes at output control 1, duty cycle 20, in a melting-ice bath. Either cell disruption method left approximately 5-10% unbroken cells. The nuclei, cell debris, and resting intact cells were then sedimented at 300 × g for 10 min. In phagocytosis experiments, this fraction also contained all the OZ (either free, enclosed in phagosomes, or bound to plasma membrane receptors). The 300 × g supernatant was free of OZ particles, as determined microscopically. A fraction enriched in azurophil granules was then obtained by centrifugation at 11,000 × g for 10 min, followed by separation of the granule-free membranes and the cytosol at 200,000 × g for 45 min. Marker proteins, human leukocyte antigen class I (plasma membrane marker), and myeloperoxidase (azurophil granule marker), were assayed by enzyme-linked immunosorbent assay (6).
Solubilization and Immunoprecipitation of Hck, and in Vitro PTK Activity AssayHck was solubilized from NB4 cells or cell
fractions with a buffer containing 2% Nonidet P-40 (1), then
immunoprecipitated and assayed for its in vitro PTK activity
in the presence of acid-treated enolase as exogenous substrate, 10 mM MnCl2, 10 µM MgATP, and 10 µCi of [-32P]ATP (6000 mCi/mmol), as described (1,
6). In the kinase assay, both Hck autophosphorylation and
phosphorylation of the exogenous substrate enolase by Hck were
measured. During cell stimulation, these activities changed in
parallel, but under "Results" only phosphorylation of enolase by
Hck is shown. The relative specific activity of Hck was calculated
dividing the PTK activity by the relative quantity of Hck in a sample.
The relative quantity of Hck protein was estimated by Western blotting
of immunoprecipitates that were done with affinity-purified anti-Hck
IgG covalently coupled to CNBr-activated Sepharose beads (from
Pharmacia Biotech Inc.) according to the manufacturers instructions, in
parallel to the measurement of PTK activity. For solubilization and
immunoprecipitation of Hck from human neutrophils, the 200,000 × g supernatant of a sonicate of non-differentiated NB4 cells
was used (at 500 µg of protein/ml) instead of water in all buffers,
in order to compete out the proteolysis of Hck by azurophil-granule
protease(s), as described (1, 6).
Proteins were separated by 8% SDS-PAGE, transferred to nitrocellulose, blotted with affinity purified anti-Hck IgG, and revealed by 125I-protein A or ECL (Amersham) as described previously (6). Quantification of Hck on Western blots was done by densitometric scanning of autoradiograms using the Elecphor program (CRIS, Labege, France).
In neutrophils, the granular form of Hck is highly susceptible to degradation by azurophil-granule-associated protease(s) (1, 6). To study granular neutrophil Hck, this proteolysis has to be competed out in a manner that is technically only feasible on a small scale (1, 6). Therefore, we searched for another cell system with similar expression and subcellular localization of Hck, but less proteolytic activity than neutrophils. The human promyelocytic NB4 cell line can be differentiated into neutrophil-like cells with retinoic acid. Like other myeloid cell lines, NB4 cells have only one granule population, the azurophil granules, but regarding other maturation markers, NB4 cells have the phenotype closest to mature neutrophils (20).
Expression of Hck, Acquisition of NADPH Oxidase Activity, and Degranulation during NB4 Cell Differentiation
In non-differentiated NB4 cells, Hck was undetectable by Western
blotting (Fig. 1A) or in vitro PTK
activity assays of whole cell lysates (Fig. 1B). Upon
differentiation of NB4 cells with 1 µM
all-trans-retinoic acid (20), Hck became expressed, reaching a plateau of expression at day 5. The acquisition of elementary features of mature granulocytes, a functional NADPH oxidase activity (Fig. 1C), and the capability to mobilize their azurophil
granules (Fig. 1D), was also investigated. These cellular
responses appeared in parallel to Hck expression. Acquisition of the
third major granulocyte response, phagocytosis, during retinoic acid
differentiation of NB4 cells has been reported earlier (24). Therefore,
in all further experiments, NB4 cells were differentiated for 5 days with 1 µM all-trans-retinoic acid in order to
obtain neutrophil-like cells.
Hck Is Mainly Localized in the Secretory Granule Fraction of NB4 Cells, and Different Forms Are Found in Different Fractions
When neutrophils are disrupted and the post-nuclear supernatant is
fractionated by differential centrifugation, Hck is mainly found in the
secretory granule fraction; it is also present in granule-free
membranes and the cytosol (6). To further validate the NB4 cell model,
we verified that the distribution of Hck in differentiated NB4 cells
was similar to that in neutrophils. The secretory granule fraction (G),
which contained nearly all the azurophil-granule marker
(myeloperoxidase; Fig. 2A), also contained most of Hck (Fig. 2, B and C). Since this NB4
cell fraction G was contaminated with plasma membrane marker (human
leukocyte antigen class I), it was defined as a granule-enriched
fraction. The non-granular membranes (M) and cytosol (C) were
essentially free of contaminating markers (Fig. 2A) and
contained small amounts of Hck (Fig. 2, B and C).
Quantification of the Western blot in Fig. 2B by
densitometric scanning showed that 55% of the total cellular Hck was
present in the granule-enriched fraction, 12% in the granule-free
membranes, and 14% in the cytosol. Some Hck (18%) was also present in
the nuclear pellet, corresponding to the remaining intact cells and
contaminating granules. In addition, the partitioning of the different
Hck isoforms between the subcellular fraction was similar in NB4 cells
and neutrophils (6). The granule-enriched fraction contained more
p61hck than p59hck, whereas the situation was inverse
in the granule-free membranes, and the cytosol contained exclusively
soluble p61hck (Fig. 2B). Importantly, the
protease(s) that degrades the granular form of Hck in neutrophils was
either not present, or not active, in NB4 cells. This cell line
constitutes therefore an adequate cell line for our study.
OZ, A23187, fMLP, and PMA Differentially Activate NADPH Oxidase and Degranulation in NB4 Cells
Before studying Hck activation, we screened various stimuli that
are widely used in neutrophil activation for their efficiency to
stimulate retinoic acid-differentiated NB4 cells. The cells were
stimulated for various periods of time with the receptor agonists OZ or
fMLP, or with stimuli that by-pass membrane receptors, PMA or A23187.
The efficiency of these agents to stimulate the NADPH oxidase response
was of the following order: PMA > OZ fMLP > A23187
(Fig. 3A). For azurophil granule exocytosis,
it was OZ > PMA > A23187, while fMLP did not stimulate
degranulation (Fig. 3B). PMA was quite a good secretory
stimulus, like in differentiated HL60 neutrophil-like cells (25),
although it does not induce secretion of azurophil granules in human
neutrophils. OZ is, in addition, a particulate stimulus that is
phagocytosed by the cells. Therefore, using these stimuli, which can
elicit either one or more of the cellular responses, we were able to
test whether Hck could be involved in the signal transduction pathways
that they activate.
OZ and A23187, but Not PMA, Activate Hck in NB4 Cells and Human Neutrophils
OZ and A23187, but not PMA, activated Hck in retinoic
acid-differentiated NB4 cells (Fig. 4). Activation of
Hck was 1.7-fold over the basal activity of the kinase, it occurred
within seconds of adding the stimuli to the cells, and it was
transient, being back to basal at 30 min (see also Fig. 6). The Hck
response to OZ was biphasic, with a first sharp peak at 0.5 min, and a
plateau-like high activity between 5 and 10 min of stimulation.
A23187-induced Hck activation resembled somewhat the OZ response.
In NB4 cells, Hck was also activated by fMLP, in a weaker (1.4-fold)
and more transient manner (back to basal at 7.5 min).
We studied whether the activation of Hck by these stimuli was similar
in human neutrophils. As in NB4 cells, OZ and A23187 activated Hck in
neutrophils, with similar efficiency, whereas PMA did not significantly
affect it (Fig. 5). A difference between the two cell
types was that the weak activation of Hck by fMLP was not found in
neutrophils. Now that we had identified stimuli that activate Hck, we
could examine next whether the different subcellular fractions of Hck
might be activated differentially.
Activation of Hck in Subcellular Fractions of NB4 Cells
OZ Activates Hck in the Granule- and the OZ-containing FractionsStimulation of human neutrophils with OZ provokes translocation of Hck with the azurophil granules to the OZ-containing phagosomes (6). Therefore, in experiments with OZ, a fourth NB4 cell fraction, the OZ-containing fraction, was recovered.
Hck activation was strongest (2-3-fold) in the granule-enriched and in the OZ-containing fractions (Fig. 6). Activation in the OZ-containing fraction was biphasic with a first peak between 0.5 and 1.5 min and a second one at 5 min. Activation in the granule-enriched fraction occurred between 5 and 10 min of stimulation. As approximately 55% of the total Hck activity per cell is localized in the granule-enriched fraction (see Fig. 2), activation in this fraction accounted for most of the effect seen with OZ in whole cell lysates. The cytosolic form of Hck was also weakly activated, but Hck in the granule-free membrane fraction was not activated at all. These results show that the different forms of Hck, in their respective subcellular compartments, can be activated selectively during OZ signal transduction.
We tested whether activation of Hck by OZ was due to translocation of
Hck protein into the respective subcellular fractions. Translocation
was monitored by Western blotting (Fig. 7) and
quantified by densitometric scanning of the blots. As expected, Hck
translocated progressively into the OZ-containing fraction during cell
stimulation (panel O, 2.5-fold at 30 min compared to zero
time) whereas it decreased concomitantly in the granule-enriched
fraction (panel G, 0.6-fold at 30 min). Hck also accumulated
in the granule-free membrane fraction and weakly in the cytosol
(panel M, 2.4-fold, and panel C, 1.3-fold at 30 min). Western blots of whole cell lysates (panel L) are
shown to demonstrate that the overall amount of Hck in the cell did not
change during the incubation period. Both isoforms of Hck,
p59hck and p61hck, translocated between the membrane
fractions, and apparently with similar kinetics. The slight
accumulation of p61hck in the cytosol suggests that a small
amount of the membrane-bound form was converted to the soluble form of
p61hck during cell stimulation. The Western blots therefore
show that Hck activation by OZ (shown in Fig. 6) resulted in some
fractions from translocation of Hck but was largely caused by an
increase in specific activity. The relative specific activity of Hck in the different fractions is determined below for the various stimuli (Table I).
|
When cells were stimulated with A23187, Hck was activated 2-3-fold in the granule-enriched membrane fraction and, unlike with OZ, in the granule-free membrane fraction (Fig. 6). Hck activation in the granule-free membranes was 1.8-fold, rapid, and transient (back to basal activity at 5 min). Further differences to the OZ response were revealed by determination of the translocation events. After 10 min, Hck protein accumulated approximately 1.5-fold in the granule-enriched fraction, whereas it decreased in the granule-free membranes to half of the level in resting cells (Fig. 7). The amount of Hck in the cytosol did not change in A23187-stimulated cells during the incubation period.
fMLP Has a Weak Effect on Hck in the Granule-enriched Fraction and the Cytosol, and PMA Does Not Activate Hck in Any FractionFinally, we checked whether the weak effect of fMLP, and the lack of effect of PMA, on Hck activity in the whole cell lysates of NB4 cells, might be due to simultaneous activation and inhibition of Hck in different fractions. This was not the case. When the cells were stimulated with fMLP, Hck was activated 1.4-fold in the granule-enriched fraction and in the cytosol (Fig. 6), yielding a similar profile to that seen in whole cell lysates. PMA did not affect the activity of any Hck fraction (Fig. 6). Furthermore, neither fMLP nor PMA caused translocation of Hck between the fractions (maximal changes were 0.9- and 1.2-fold of the controls after 7.5 min of stimulation with fMLP, or after 30 min of stimulation with PMA, respectively) (Fig. 7).
Specific Activity of Hck in Fractions of Stimulated NB4 CellsFor calculation of the relative specific activity, Hck protein was quantitated by Western blotting after its immunoprecipitation from fractions showing peaks of activation and from the respective zero time controls, i.e. the quantity of Hck was determined under the same conditions as the kinase activity. This method of Hck quantification gave similar results to the data obtained from the Western blots shown in Fig. 7 that were peformed without prior immunoprecipitation (Table I). In the case of NB4 cell stimulation with OZ, Hck activation in the granule-enriched fraction was due to an approximately 5-fold increase in specific activity, whereas activation in the cytosol was caused by accumulation of Hck protein. Activation in the OZ-containing fraction was a combination of translocation and increase in specific activity. On the contrary, when the cells were stimulated with A23187, the increase in relative specific Hck activity was moderate in the granule-enriched fraction (1.7-fold), while it was 3-fold in the granule-free membrane fraction. Stimulation with fMLP caused a weak increase in relative specific Hck activity in both the granule-enriched fraction and the cytosol.
Src family PTKs are regulators of a great variety of signal transduction events. Several of them, particularly Hck, are multicompartmental enzymes. This has given rise to the hypothesis that the sequestration of these kinases into several compartments might govern their involvement in distinct pathways. Our study shows that OZ and A23187, which produce similar activation profiles of Hck in whole cells, activate distinct subcellular fractions of Hck.
In this study, we have compared the particulate stimulus OZ with three
soluble stimuli. They elicited to various degrees the granulocyte
responses of NADPH oxidase and degranulation and, in addition, OZ
induced phagocytosis. We have demonstrated that OZ and A23187 activate
Hck in NB4 cells and human neutrophils. Hck activation was rapid and
transient, consistent with a role of the kinase in early OZ and A23187
signaling. The level of activation was similar in both cell types, and
it was comparable to those reported for the activation of Hck in
FcR-dependent signaling (9), or for other Src family
PTKs, like Fgr in integrin-mediated neutrophil activation (26), or Lyn
in fMLP signaling (27). Signaling by the particulate stimulus OZ is
partially mediated by receptors for the opsonic factors, Fc
Rs and
complement receptors (a subgroup of integrins), and Hck is known to be
one of the PTKs that mediate Fc
R and integrin signaling (7, 8, 9, 10, 16).
Hck activation by A23187, in the presence of 1.5 mM calcium in the extracellular medium, is in line with two other reports that
have shown an implication of Src in calcium-related signaling (28,
29).
fMLP and PMA are two other potent activators of granulocyte responses, and signaling by both stimuli involves tyrosine phosphorylation (see Ref. 1, and references therein). Recently, Lyn has been identified as one of the PTKs activated by fLMP in neutrophils (27, 30). In our study, Hck was only weakly activated by fMLP in NB4 cells, and not in neutrophils, while Lyn was activated 2.5-fold under the same conditions (data not shown). Thus, it is unlikely that Hck could play a key role in fMLP signaling. PMA did not activate Hck at any time up to 30 min. Together, our findings suggest that Hck is involved in OZ and A23187-induced pathways leading to early granulocyte responses, but not in PMA-generated signals.
It has recently been proposed that Hck could be activated subsequently
to the respiratory burst response, by NADPH oxidase-derived superoxide
anions (31). This was based on the observations that O2 can stimulate
tyrosine phosphorylation (31, 32) and that both NADPH oxidase and Hck
activities increased in GTP
S-stimulated permeabilized neutrophils
(31). We show here in intact cells, that there is no apparent
correlation between increases in Hck and NADPH oxidase activities.
Indeed, PMA, by far the most powerful stimulus for
O2
production in
neutrophils and NB4 cells, did not activate Hck.
Having identified stimuli that activate Hck in whole cells, next we
tested whether different subcellular fractions of Hck can be activated
selectively. OZ strongly activated Hck in the granule- and
OZ-containing fractions, weakly in the cytosol, and not at all in the
granule-free membranes. While activation in the granule-enriched
fraction was due to a strong increase in its specific activity, Hck
activation in the OZ-containing and cytosolic fractions was rather
caused by translocation of the kinase into these compartments.
Accumulation of Hck in the OZ-containing fraction was consistent with
the phagosome-granule fusion events that accompany phagocytosis (17),
and translocation to the cytosolic fraction upon cell stimulation has
been reported earlier for Src in platelet-derived growth
factor-stimulated platelets (33). The finding that Hck was not
activated in the granule-free membrane fraction was unexpected, since
this fraction contains the plasma membrane, and therefore FcRIIIB
and integrins. As OZ particles sediment at 300 × g,
the receptors bound to OZ might co-sediment during this centrifugation
step; it is therefore possible that part of the Hck activation in the
OZ-containing fraction results from plasma-membrane receptor
triggering.
A23187 also selectively activated Hck in certain subcellular compartments, in the granule-enriched and granule-free membrane fractions, but not in the cytosol. Increase in the specific kinase activity was stronger in the granule-free fraction than in the granule-enriched fraction. This could be the result of potential differences between the calcium sensitivity of the p59hck and p61hck isoforms which are predominant in the granule-free and the granule-enriched fraction, respectively. This hypothesis is currently under investigation in the laboratory. Thus, the effects of OZ and A23187 on Hck activity are complex, as they involve translocation of the kinase and selective activation in distinct subcellular fractions.
The cell fractionation approach permitted us to show that although the profiles of Hck activation by OZ and A23187 were quite similar in whole cell lysates, the stimuli affected different subcellular fractions. OZ augmented the specific Hck activity in the granule-enriched fraction by 5-fold, while A23187 produced a stronger increase in specific Hck activity in the granule-free membrane fraction (3-fold) than in the granule-enriched membranes (1.7-fold). Therefore, comparison of the effects of OZ and A23187 on Hck by subcellular fractionation has demonstrated that different stimuli can activate distinct fractions of Hck.
It will be important to determine whether the activation is due to one or both isoforms of Hck, p59hck and p61hck. Unfortunately, the bands of membrane-bound Hck on Western blots do not comigrate with the multiple autophosphorylation bands in the kinase assay, since both isoforms of Hck are phosphorylated. Therefore, it is impossible to distinguish between the isoforms in the kinase assay and to correlate them to the two bands quantified by Western blotting. Isoform-specific antibodies would be necessary to investigate this question further, but such antibodies are currently not available.
Src family PTK activation in selected subcellular compartments has been shown once before in our laboratory. The specific activity of the Src family PTK Lck increases 1.6-fold upon internalization of the kinase to endosomal structures in CD2-triggered T lymphocytes (34). Other reports have shown activation of several Src family PTKs in Triton X-100-insoluble fractions (7, 35, 36). It seems therefore that selective activation of Src family PTKs in distinct subcellular compartments, together with translocation events, are general behavior of these kinases.
Since the localization of proteins is crucial for their functional role, we have attempted to establish a correlation between the subcellular fractions in which Hck is activated, and the cell responses elicited by a given stimulus. We have shown here that, upon cell stimulation with OZ, which is a potent inducer of azurophil granule mobilization, Hck activation was strongest in the granule-enriched fraction. Together with our observations that Hck is mainly localized in the granular fraction and translocates with the azurophil granules toward the phagosomal membrane during OZ-induced phagocytosis in neutrophils and HL60 cells (6), this report suggests that Hck could regulate phagocytosis-linked degranulation. Since A23187 also activates Hck in the granule-enriched fraction, although with a weaker increase in specific activity, the putative role of Hck in the secretory process seems not be restricted to secretion of azurophil granules toward phagosomes, but to be more general. Furthermore, on the signal transduction pathways leading to degranulation, Hck should be either situated upstream of protein kinase C or in an independent pathway. This can be deduced from our results showing that PMA, although a good stimulus for degranulation in NB4 cells, does not involve Hck in its signaling mechanisms.
Other investigations of the subcellular localization of Src family PTKs have revealed that, apart from Hck, Fgr and Src are also present on secretory vesicles (6, 37, 38, 39, 40). Therefore, it has long been suggested that these kinases could play a role in the secretory process. However, before this study, it has never been attempted to measure PTK activities in secretory compartments isolated from cells undergoing secretion. Our results show that subcellular fractionation could be a valuable tool to correlate PTK activation to cellular responses.
In conclusion, this work shows that Hck can be differentially activated in its various subcellular compartments. This could give the kinase access to several discrete sets of effectors and substrates, thus enabling it to serve more than one function within a cell. We propose that one of the functions of Hck could be the regulation of degranulation.
We gratefully acknowledge Michel Lanotte for the gift of the NB4 cell line and Honoré Mazarguil for the preparation of immunogen anti-Hck peptide.